Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...

Medtronic (MDT) announced the FDA has cleared the Hugo robotic-assisted surgery, or RAS, system for use in urologic surgical procedures. The Hugo ...

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting Primary safety and effectiveness ...

Medtronic plc (NYSE:MDT) ranks among the best medical device stocks to invest in. Following a tour of the company’s HUGO soft tissue surgical robotic facility in Boston, Stifel maintained its Hold ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top five robotic surgeons in the U.S. James Porter serves as medical director of ...

Already worth billions of dollars, the global surgical robotics market will double by 2029, according to a new MassDevice ...

Minneapolis-based Medtronic, the world’s largest standalone medical device manufacturer, is developing a new robotic surgical system expected to be released by 2019. Robotically assisted surgery ...

If you buy companies with in-demand products and hold for the long term, you can end up with long-term winners.